116 related articles for article (PubMed ID: 6313894)
1. Potentiation of the antithrombotic effect of prostacyclin by simultaneous administration of aminophylline in a canine model of coronary artery thrombosis.
Romson JL; Hook BG; Lucchesi BR
J Pharmacol Exp Ther; 1983 Nov; 227(2):288-94. PubMed ID: 6313894
[TBL] [Abstract][Full Text] [Related]
2. Influence of prostacyclin on coronary thrombosis and myocardial ischemia in conscious canine experiments.
Fiedler VB; Mardin M
Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):114-27. PubMed ID: 3913392
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
4. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR
J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of epinephrine-exacerbated coronary thrombus formation by prostacyclin in the dog.
Bertha BG; Folts JD
J Lab Clin Med; 1984 Feb; 103(2):204-14. PubMed ID: 6363581
[TBL] [Abstract][Full Text] [Related]
6. Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death.
Fiedler VB; Mardin M
Basic Res Cardiol; 1986; 81(1):40-53. PubMed ID: 3521579
[TBL] [Abstract][Full Text] [Related]
7. Primary prevention of coronary arterial thrombosis with the factor Xa inhibitor rTAP in a canine electrolytic injury model.
Lynch JJ; Sitko GR; Lehman ED; Vlasuk GP
Thromb Haemost; 1995 Aug; 74(2):640-5. PubMed ID: 8585000
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic efficacy of a recombinant nematode anticoagulant peptide (rNAP5) in canine models of thrombosis after single subcutaneous administration.
Rebello SS; Blank HS; Rote WE; Vlasuk GP; Lucchesi BR
J Pharmacol Exp Ther; 1997 Oct; 283(1):91-9. PubMed ID: 9336312
[TBL] [Abstract][Full Text] [Related]
9. Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium.
Einzig S; Sotomora R; Rao GH; Gerrard JM; Foker JE; White JG
Prostaglandins Med; 1980 Sep; 5(3):209-19. PubMed ID: 6997909
[TBL] [Abstract][Full Text] [Related]
10. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
Lynch JJ; Cook JJ; Sitko GR; Holahan MA; Ramjit DR; Mellott MJ; Stranieri MT; Stabilito II; Zhang G; Lynch RJ
J Pharmacol Exp Ther; 1995 Jan; 272(1):20-32. PubMed ID: 7815334
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis.
Cook JJ; Gardell SJ; Holahan MA; Sitko GR; Stump GL; Wallace AA; Gilberto DB; Hare TR; Krueger JA; Dyer DL; Sanderson PE; Vacca JP; Shafer JA; Lynch JJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):503-10. PubMed ID: 10087043
[TBL] [Abstract][Full Text] [Related]
12. The beneficial effects of oral ibuprofen on coronary artery thrombosis and myocardial ischemia in the conscious dog.
Romson JL; Bush LR; Haack DW; Lucchesi BR
J Pharmacol Exp Ther; 1980 Oct; 215(1):271-8. PubMed ID: 7452488
[TBL] [Abstract][Full Text] [Related]
13. Epoprostenol (PGI2) prevents postischemic ventricular fibrillation and improves outcome in a canine model of sudden death.
Jouve R; Puddu PE; Langlet F; Guillen JC; Gautier T; Cano JP; Serradimigni A
J Pharmacol; 1985; 16(2):139-57. PubMed ID: 3903352
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of a thromboxane synthase inhibitor or prostacyclin in combination with a phosphodiesterase inhibitor for prevention of experimental thrombosis and sudden death in rabbits.
Smith EF; Egan JW
J Pharmacol Exp Ther; 1987 Jun; 241(3):855-60. PubMed ID: 3298621
[TBL] [Abstract][Full Text] [Related]
15. Anti-thrombotic effects of CX-397, a recombinant hirudin analog, in a canine model of coronary artery thrombosis.
Ohyama T; Hori T; Moriike M; Asano T; Hayashi H; Iwade K; Hosoda S
Thromb Haemost; 1998 Feb; 79(2):423-30. PubMed ID: 9493602
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of thrombus formation by endothelin-1 in canine models of arterial thrombosis.
Leadley RJ; Humphrey WR; Erickson LA; Shebuski RJ
Thromb Haemost; 1995 Dec; 74(6):1583-90. PubMed ID: 8772241
[TBL] [Abstract][Full Text] [Related]
17. Spinal cord protection with the use of prostacyclin during aortic occlusion.
Katircioğlu SF; Saritas Z; Yücel D; Bayazit M; Taşdemir O; Bayazit K
J Surg Res; 1996 Sep; 65(1):77-81. PubMed ID: 8895610
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
Pawlak R; Chabielska E; Golatowski J; Azzadin A; Buczko W
Thromb Haemost; 1998 Jun; 79(6):1208-12. PubMed ID: 9657449
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis.
Lewis GD; Witzke C; Colon-Hernandez P; Guerrero JL; Bloch KD; Semigran MJ
J Am Coll Cardiol; 2006 Apr; 47(7):1471-7. PubMed ID: 16580539
[TBL] [Abstract][Full Text] [Related]
20. Intravenous administration of prostacyclin in rabbits: elimination kinetics and blood pressure response.
Skrinska VA; Lucas FV; Chisolm GM; Hesse BL
J Lab Clin Med; 1986 Mar; 107(3):187-93. PubMed ID: 3512745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
